Détecter et évaluer l’impact desmédicaments anticholinergiques [Detecting and assessing the impactof anticholinergic medications]

Détails

ID Serval
serval:BIB_6F7D75E34958
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Titre
Détecter et évaluer l’impact desmédicaments anticholinergiques [Detecting and assessing the impactof anticholinergic medications]
Périodique
Revue medicale suisse
Auteur(s)
Csajka C., Brémond C., Lang P.O.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Statut éditorial
Publié
Date de publication
08/11/2017
Peer-reviewed
Oui
Volume
13
Numéro
582
Pages
1931-1937
Langue
français
Notes
Publication types: Journal Article
Publication Status: ppublish
Résumé
Limitation of inappropriate prescribing must be a medical concern in daily practice especially in older patients. In particular, anti-cholinergic drugs (anti-ACh), which are not all explicitly classified as anti-ACh, are commonly prescribed for a wide range of indications (pulmonary obstructive diseases, anxiety, insomnia, urinary incontinence, Parkinson's disease, congestive heart failure). Their prescription is however associated with a reduced quality of life and increased morbidity and mortality. Tools detecting inappropriate prescriptions and clinical scales that quantify the anti-ACh burden contribute, despite some limitations, to secure and optimize these drugs' prescription in this vulnerable population.
Mots-clé
Cholinergic Antagonists/adverse effects, Cholinergic Antagonists/therapeutic use, Drug Prescriptions, Humans, Inappropriate Prescribing, Quality of Life
Pubmed
Création de la notice
22/11/2017 10:38
Dernière modification de la notice
20/08/2019 14:28
Données d'usage